Allworth Financial LP Biotechnology

Allworth Financial LP

$17.4 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ALLO Allogene Therapeutics, Inc.	$186M	$0 0.0% of portfolio	340	Q1 2025 Reduced 15.63%
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	743	Q3 2024 Added 806.1%
ATOS Atossa Therapeutics, Inc.	$109M	$0 0.0% of portfolio	702	Q1 2021 New
AURA Aura Biosciences, Inc.	$179M	$0 0.0% of portfolio	66	Q1 2025 Added 50.0%
BEAM Beam Therapeutics Inc.	$1.2B	$0 0.0% of portfolio	35	Q1 2025 Reduced 46.97%
CADL Candel Therapeutics, Inc.	$170M	$0 0.0% of portfolio	45	Q1 2025 New
CRDF Cardiff Oncology, Inc.	$153M	$0 0.0% of portfolio	100	Q2 2021 Reduced 89.56%
CLDX Celldex Therapeutics, Inc.	$913M	$0 0.0% of portfolio	29	Q1 2025 Added 61.11%
CVM Cel Sci Corp	$101M	$0 0.0% of portfolio	121	Q2 2017 New
CGEN Compugen LTD	$154M	$0 0.0% of portfolio	270	Q4 2020 New
CRMD Cor Medix Inc.	$526M	$0 0.0% of portfolio	140	Q4 2023 New
CRNX Crinetics Pharmaceuticals, Inc.	$1.74B	$0 0.0% of portfolio	5	Q1 2025 Reduced 44.44%
DAWN Day One Biopharmaceuticals, Inc.	$511M	$0 0.0% of portfolio	23	Q1 2025 Added 283.33%
EDIT Editas Medicine, Inc.	$124M	$0 0.0% of portfolio	376	Q1 2025 Added 16.41%
TRDA Entrada Therapeutics, Inc.	$255M	$0 0.0% of portfolio	36	Q1 2025 New
ERAS Erasca, Inc.	$192M	$0 0.0% of portfolio	213	Q1 2025 New
FATE Fate Therapeutics Inc	$130M	$0 0.0% of portfolio	4	Q4 2024 Reduced 90.24%
GLPG Galapagos Nv	$1.84B	$0 0.0% of portfolio	9	Q1 2025 Reduced 57.14%
HUMA Humacyte, Inc.	$275M	$0 0.0% of portfolio	200	Q1 2025 Reduced 26.47%
IBRX Immunity Bio, Inc.	$1.16B	$0 0.0% of portfolio	105	Q1 2025 New
IMNM Immunome Inc.	$112M	$0 0.0% of portfolio	120	Q1 2025 New
JANX Janux Therapeutics, Inc.	$1.03B	$0 0.0% of portfolio	23	Q4 2024 Reduced 11.54%
KALV Kal Vista Pharmaceuticals, Inc.	$323M	$0 0.0% of portfolio	31	Q1 2025 New
LTRN Lantern Pharma Inc.	$35M	$0 0.0% of portfolio	100	Q1 2023 New
LQDA Liquidia Corp	$1.07B	$0 0.0% of portfolio	12	Q4 2024 New
MRVI Maravai Lifesciences Holdings, Inc.	$285M	$0 0.0% of portfolio	134	Q1 2025 Reduced 80.66%
MRUS Merus N.V.	$2.57B	$0 0.0% of portfolio	5	Q1 2025 New
NUVL Nuvalent, Inc.	$3.36B	$0 0.0% of portfolio	5	Q1 2025 New
PRTA Prothena Corp Public LTD CO	$237M	$0 0.0% of portfolio	47	Q1 2025 Added 123.81%
RGNX Regenxbio Inc.	$361M	$0 0.0% of portfolio	65	Q1 2025 New
SAGE Sage Therapeutics, Inc.	$403M	$0 0.0% of portfolio	117	Q1 2025 Reduced 57.14%
SANA Sana Biotechnology, Inc.	$485M	$0 0.0% of portfolio	210	Q1 2025 Reduced 32.91%
SGMO Sangamo Therapeutics, Inc	$76.7M	$0 0.0% of portfolio	1,000	Q2 2024 Reduced 33.2%
SRRK Scholar Rock Holding Corp	$1.57B	$0 0.0% of portfolio	24	Q3 2024 New
SWTX Spring Works Therapeutics, Inc.	$2.92B	$0 0.0% of portfolio	11	Q1 2025 New
SNDX Syndax Pharmaceuticals Inc	$631M	$0 0.0% of portfolio	34	Q1 2025 Reduced 78.62%
TERN Terns Pharmaceuticals, Inc.	$134M	$0 0.0% of portfolio	85	Q1 2025 New
TBPH Theravance Biopharma, Inc.	$719M	$0 0.0% of portfolio	43	Q1 2025 Reduced 67.91%
TRVI Trevi Therapeutics, Inc.	$353M	$0 0.0% of portfolio	20	Q1 2025 New
TYRA Tyra Biosciences, Inc.	$445M	$0 0.0% of portfolio	100	Q1 2025 New
VALN Valneva Se	$434M	$0 0.0% of portfolio	7	Q1 2024 New
VERV Verve Therapeutics, Inc.	$343M	$0 0.0% of portfolio	44	Q1 2025 Reduced 80.62%
VRDN Viridian Therapeutics, Inc.\De	$577M	$0 0.0% of portfolio	33	Q1 2025 New
VYGR Voyager Therapeutics, Inc.	$128M	$0 0.0% of portfolio	11	Q1 2025 Reduced 78.43%
XENE Xenon Pharmaceuticals Inc.	$1.91B	$0 0.0% of portfolio	12	Q3 2024 Added 140.0%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.